Medical Research Council

Medical Research Council

Signal active

Investment Firm

Overview

At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems. A royal commission, entitled The Royal Commission Appointed to Inquire into the Relations of Human and Animal Tuberculosis, was set up in 1901. It aimed to find out whether tuberculosis in animals and humans was the same disease and whether animals and humans could infect each other. This page describes how, by 1919, the Commission had evolved into the independent Medical Research Council.

Highlights

Founded

1913

Industry

Health Care

Employees

1001-5000

Investment

3

Lead Investment

2

Exits

undefined

Stages

N/A

Investor Type

N/A

Location

Europe

Contact Information

Social

Profile Resume

Medical Research Council, established in 1913 and headquartered in Europe., specializes in investments across Education, Higher Education, Universities, Health Care, Medical, Charity, Oncology, Financial Services, Biotechnology, Infrastructure. Their recent investments include University of Nottingham, North East Innovation Lab, Cancer Research UK, Engineering and Physical Sciences Research Council, Aclipse Therapeutics. The highest investment round they participated in was $54.3M. Among their most notable exits are University of Nottingham and North East Innovation Lab. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace John Savill

John Savill

Chief Executive

imagePlace Tony Peatfield

Tony Peatfield

Corporate Affairs Director

imagePlace Hugh Dunlop

Hugh Dunlop

Finance Director

imagePlace Sandy Bulger

Sandy Bulger

Director of Major Projects

imagePlace Sally Smith

Sally Smith

HR Director

Investment portfolio

Medical Research Council has made 3 investments. Their most recent investment was on Nov 07, 2023, when University of Nottingham raised $1.4M.

investments

3

Diversity investments

0

Lead investments

2

Number of exits

undefined

Investments

3

Annouced DateOrganization NameIndustryMoney Raised
Jan 26, 2021
Aclipse Therapeutics Aclipse Therapeutics
Biotechnology2.2M
Jul 28, 2022
North East Innovation Lab North East Innovation Lab
Health Care265.4K
Nov 07, 2023
University of Nottingham University of Nottingham
Education1.4M

Exits

0

Funding Timeline

Funding rounds

3

Investors

1

Funds

0

Funding Rounds

3

Medical Research Council has raised 3 rounds. Their latest funding was raised on Nov 07, 2023 from a Grant - University of Nottingham round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jan 26, 2021
Grant - Aclipse Therapeutics Grant - Aclipse Therapeutics
-2.2M-
Jul 28, 2022
Grant - North East Innovation Lab Grant - North East Innovation Lab
-265.4K-
Nov 07, 2023
Grant - University of Nottingham Grant - University of Nottingham
-1.4M-

Investors

1

Medical Research Council is funded by 1 investor(s). University College London (UCL) Kantor is the most recent investors.

Investor NameLead InvestorFunding RoundMoney Raised
University College London (UCL) University College London (UCL)
Yes
Grant - Medical Research Council
55.9M

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.